Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform ...
A new experimental study demonstrates that combining multiplex PCR with high-resolution melting analysis can rapidly identify ...
A new PCR-based study in Venezuela shows that msp5-targeting diagnostics outperform msp2 primers for detecting Anaplasma ...
Google's aptamer agent hit rate fell from 10.2% to 3.7% before reaching 33.5%. People ran the lab, while the robot layer was tested on dye. The cheap design-and ...
VITALiS and Applied BioCode today announced an expanded collaboration to support the adoption and internalization of gastrointestinal (GI) pathogen testing in commercial and physician office ...
Purpose To understand the molecular epidemiological and clinical characteristics of norovirus in children with acute ...
Intervertebral disc degeneration (IVDD), driven by progenitor cell loss and oxidative stress, remains a major clinical ...
Current genetic engineering techniques enable protein modulation at the DNA/RNA levels. Here, the authors design an RNA platform to bring target protein and effector enzyme into proximity, realizing ...
Macrophages play a key role in cardiac injury and repair after myocardial infarction (MI). Salt-inducible kinase 2 (SIK2), a ...
A suspected plague death has renewed scrutiny of India's readiness for pneumonic plague. An infectious disease expert said ...
Acciones de Novacyt hoy: rentabilidad y valor bursátil de la acción. Consulte la cotización de Novacyt en bolsa (EPA:ALNOV) y su último precio: 0,4640.